Kenneth Ross

5PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

|Jul 12, 2020
suz12 inactivation in p53- and nf1-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor types.

Felix Oppel, Dong H Ki, Mark W Zimmerman

|Feb 18, 2020
Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers.

Mihriban Karaayvaz-Yildirim, Rebecca E Silberman, Adam Langenbucher

|Apr 11, 2019
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.

Felix Oppel, Ting Tao, Hui Shi

|Sep 30, 2018
Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras.

S Haihua Chu, Evelyn J Song, Jonathan R Chabon

Pageof 1

Frequent Collaborators

2 joint publications

Felix Oppel

2 joint publications

A Thomas Look

1 joint publications

Mark W Zimmerman

1 joint publications

Shuning He